Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Mitos e verdades sobre bioestimuladores de colágeno


News provided by

Galderma

Apr 04, 2023, 11:01 ET

Share this article

Share toX

Share this article

Share toX

Produtos que ajudam o corpo a produzir colágeno geram curiosidade quando se trata dos seus resultados e eficácia

SÃO PAULO, 4 de abril de 2023 /PRNewswire/ -- Responsável pela firmeza e sustentação da pele, o colágeno é uma proteína produzida naturalmente pelo corpo. Um fator importante é que, após os 20 anos de idade, essa produção começa a diminuir cerca de 1% ao ano¹.

Continue Reading

Segundo a cirurgiã plástica Dra. Ingrid Luckmann (CRM-SC 12912), com menor quantidade dessa proteína, a pele passa a ficar mais fina e sem elasticidade. "Conforme avançamos na idade, é comum que haja perda de colágeno, causando flacidez de pele e falta de densidade dérmica, que dá essa aparência de uma pele mais fina. Os procedimentos estéticos que estimulam o corpo a produzir mais colágeno são muito indicados para essas queixas", explica.

É o caso de Sculptra®, o bioestimulador de colágeno pioneiro, que age estimulando a pele a produzir mais colágeno, podendo aumentar sua produção em 66,5%*². O produto, além das laterais do rosto³, pode ser aplicado no corpo, como pescoço, colo, coxas, joelhos, glúteos e abdômen4,5.

Com eficácia comprovada6 observada em 20 anos de uso no mercado brasileiro, Sculptra® já conquistou celebridades como Sabrina Sato, que declarou como o produto foi um grande aliado na recuperação da firmeza de sua pele após o período de gestação. Entre homens, Sculptra® também faz sucesso por conta de seus resultados naturais. O ator Malvino Salvador, por exemplo, já comentou que não abre mão do tratamento no rosto para melhorar a qualidade de pele.

Para esclarecer algumas das principais curiosidades acerca do mecanismo de ação do bioestimulador de colágeno queridinho entre os famosos, a Dra. Ingrid Luckmann desvenda alguns mitos e verdades sobre a sua utilização.

1.  Promove o emagrecimento

Mito. Sculptra® é indicado para melhorar a qualidade da pele7, restaurar a firmeza perdida ao longo do tempo através do tratamento da flacidez de pele³ e trazer de volta sua sustentação, aumentando a espessura³.

"A flacidez de pele pode acontecer em decorrência do emagrecimento repentino – como em caso de pós cirurgias bariátricas e gravidez -, e o bioestimulador de colágeno age para amenizar essa flacidez, recuperando a qualidade da pele, sua firmeza e sustentação. Mas o produto não causa o emagrecimento", explica Dra. Ingrid. Ainda segundo a médica, em relação à face, quando se emagrece há a redução significativa de alguns coxins de gordura que são necessários para manter a sustentação da pele, e o bioestimulador de colágeno age amenizando aquele aspecto de derretimento do rosto, uma vez que devolve densidade dérmica à região. "Nesses casos, para se obter resultados ainda mais superiores, pode-se associar a aplicação de bioestimulador de colágeno com ácido hialurônico injetável. O bioestimulador age incentivando o corpo a produzir mais colágeno, enquanto o ácido hialurônico injetável auxilia suavizando incômodos de pontos estratégicos da face", comenta.

2.  Melhora celulite

Verdade. O bioestimulador de colágeno ajuda a melhorar a aparência da celulite relacionada à flacidez. Nos glúteos, por exemplo, além de ajudar no combate à celulite, ainda pode melhorar a textura da pele e volumizar a região8.

3.  Sua aplicação só é indicada após uma certa idade

Mito. A indicação de uso de Sculptra® deve ser avaliada de maneira individual por um profissional de saúde habilitado à prática de procedimentos estéticos injetáveis, não devendo ser limitada e nem guiada apenas pela idade do paciente.  

4.  Ajuda a manter a qualidade da pele

Verdade. O bioestimulador de colágeno Sculptra® ajuda a recuperar a saúde da pele, uma vez que proporciona mais firmeza, sustentação e elasticidade, colaborando, assim, para manter a qualidade de pele conforme se avança na idade3.

5.  O efeito passa rapidamente

Mito. Sculptra® age estimulando o organismo a produzir colágeno de forma gradativa e prolongada, cujo resultado pode durar até 25 meses9. O bioestimulador de colágeno Sculptra® é um aliado na restauração da estrutura da pele e renovação da firmeza natural10. É um produto utilizado em procedimentos estéticos injetáveis que devem ser realizados por profissionais de saúde habilitados à prática de injetáveis.

*Colágeno tipo I

¹Shuster S, Black MM, McVitie E. The influence of age and sex on skin thickness, skin collagen and density. Br J Dermatol. 1975;93:639-643.

²Goldberg D, Guana A, Volk A, Daro-Kaftan E.Single-arm study for the characterization of human tissue response to injectable poly-L-latic acid. Dermatol Surg. 2013;39(6):915-922.

³Machado Filho CDS, Santos TC, Rodrigues APLI, da Cunha MG. Ácido poli-l-lático: um agente bioestimulador. Surg Cosmet Dermatol. 2013;5(4):345-50.

4Haddad A, Menezes A, Guarnieri C, et al. Recommendations on the Use of Injectable Poly-L-Latic Acid for Skin Laxity in Off-Face Areas. J Drugs Dermatol. 2019;18(9):929-935.

5Kollipara R, Hoss E, Boen M, Alhaddad M, Fabi SG. A Randomized, Split-Body, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Poly-L-lactic Acid for the Treatment of Upper Knee Skin Laxity. Dermatol Surg. 2020 Dec;46(12):1623-1627.

6Data on File. JOB 0507F20 Message Recall Aesthetics w1. HSR Health. Maio 2021.

7Bohnert K et al. Dermatol Surg. 2019 May;45(5):718-724.

8Durairaj KK, Devgan L, Lee A, Khachatourian N, Nguyen V, Issa T, Baker O. Poly-L-Lactic Acid for Gluteal Augmentation found to be Safe and Effective in Retrospective Clinical Review of 60 Patients. Dermatol Surg. 2020 Oct;46 Suppl 1:S46-S53.

9Narins R, Baumann L, Brandt F et al. A randomized study of the efficacy and safety of Injectable poly-l-lactic acid versus human–based collagen implant in the treatment. J Am Acad Dermatol. 2010 Mar;62(3):448-62.

10Sculptra (Ácido poli-L-láctico) [Instrução de Utilização] Uppsala, Suécia. Q-Med AB.

Sobre a Galderma

A Galderma é a maior empresa independente de dermatologia do mundo, presente em aproximadamente 90 países. Desde a sua criação em 1981, tem sido movida por uma dedicação completa à Dermatologia, oferecendo um portfólio inovador e com base científica de marcas e serviços sofisticados em Estética, Produtos ao Consumidor e Medicamentos. Focada nas necessidades dos consumidores e pacientes, a Galderma trabalha em parceria com profissionais de saúde para garantir resultados superiores. As marcas de estética da Galderma foram consideradas, pelo segundo ano consecutivo, top of mind dos profissionais da saúde nas categorias Bioestimuladores de Colágeno e Ácido Hialurônico, segundo pesquisa realizada em 2022. A empresa segue avançando a dermatologia para cada história de pele, porque entende que a pele em que estamos molda nossas histórias de vida. Para   mais informações, visite https://www.galdermaaesthetics.com.br/

Foto - https://mma.prnewswire.com/media/2047557/Dra_Ingrid_Paula__002.jpg

FONTE Galderma

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Also from this source

Galderma establishes new U.S. headquarters in Miami and strengthens regional leadership

Galderma establishes new U.S. headquarters in Miami and strengthens regional leadership

Galderma (SIX: GALD), the pure-play dermatology category leader, today announced the establishment of its new U.S. headquarters in Miami, Florida,...

GALDERMA LAUNCHES "SCRATCH RESISTANCE" CAMPAIGN TO VALIDATE THE PHYSICAL AND EMOTIONAL BURDENS OF ATOPIC DERMATITIS

GALDERMA LAUNCHES "SCRATCH RESISTANCE" CAMPAIGN TO VALIDATE THE PHYSICAL AND EMOTIONAL BURDENS OF ATOPIC DERMATITIS

Galderma (SIX: GALD), the pure-play dermatology category leader, today announced the launch of "Scratch Resistance," its new broadcast advertisement...

More Releases From This Source

Explore

Cosmetics and Personal Care

Cosmetics and Personal Care

Health Care & Hospitals

Health Care & Hospitals

Household, Consumer & Cosmetics

Household, Consumer & Cosmetics

New Products & Services

New Products & Services

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.